Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Antigen processing and presentation | R-HSA-1236975 | map04612 | parthenolide | 7251185 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | parthenolide | 7251185 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | parthenolide | 7251185 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | parthenolide | 7251185 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | parthenolide | 7251185 | drug-path |
| Bladder cancer | R-HSA-9700206 | map05219 | parthenolide | 7251185 | drug-path |
| p53 signaling pathway | R-HSA-168638 | map04115 | parthenolide | 7251185 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | parthenolide | 7251185 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | parthenolide | 7251185 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | parthenolide | 7251185 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | parthenolide | 7251185 | drug-path |
| Vibrio cholerae infection | R-HSA-9609646 | map05110 | parthenolide | 7251185 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | parthenolide | 7251185 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | prenylamine | 36921 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | prenylamine | 36921 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | prenylamine | 36921 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | prenylamine | 36921 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | prenylamine | 36921 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | prenylamine | 36921 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | prenylamine | 36921 | drug-path |